MedPath

Yahav Dafna

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response

Phase 4
Conditions
Immunosuppression
COVID-19 Acute Respiratory Distress Syndrome
First Posted Date
2021-07-14
Last Posted Date
2021-10-08
Lead Sponsor
dafna yahav
Target Recruit Count
504
Registration Number
NCT04961229

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.